Royalty Pharma plc (RPRX)

Nasdaq · Healthcare · Biotechnology
$68.45+1.08%As of 2026-11-22 · USD
Last session low $67.95Last session high $68.83
52-week low $37.3152-week high $70.37
Market cap
$39.36B
Sector
Healthcare
P/E (TTM)
44.7x
Dividend yield
1.37%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)63.5In the neutral range (30 to 70)
MACD (12, 26, 9)1.82Below its signal line (2.10); histogram -0.28
Bollinger %B (20, 2)64%Inside the bands (64.56 to 70.64)
SMA 2067.60Price is 1.3% above
SMA 5062.31Price is 9.9% above
SMA 20055.26Price is 23.9% above
ATR (20)2.16% of priceAverage true range per day
52-week position94%In the upper part of the 37.31 to 70.37 range

About Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Insider filings, 90 daysNo purchases and 7 sales (about $32.6M).
Latest fiscal yearEnded 2025-12-31: revenue of $2.38B and an operating margin of 65.6%.

More in Biotechnology